Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jie-Fu Yang

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Chemico-Biological Interactions|June 13, 2020
An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62Hao Chen, Da-Peng Dai, Shan Zhou, et al.
Frontiers in Pharmacology|December 30, 2022
Identification and drug metabolic characterization of four new CYP2C9 variants <i>CYP2C9*72</i>-<i>*75</i> in the Chinese Han populationFang-Ling Zhao, Qing Zhang, Shuang-Hu Wang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|February 15, 2014
[Glucometabolic abnormalities survey among outpatients without previous diabetes diagnosis and with coronary artery disease and hypertension]Yun-dai Chen, Dan-dan Li, Wei Dong, et al.
Clinical Interventions in Aging|January 8, 2020
Identification of Frailty and Its Risk Factors in Elderly Hospitalized Patients from Different Wards: A Cross-Sectional Study in ChinaYao-Dan Liang, Yao-Nan Zhang, Yan-Ming Li, et al.
Pharmacology Research & Perspectives|January 28, 2021
Functional characterization of the defective CYP2C9 variant CYP2C9*18Jian Liu, Hao Chen, Shuang-Hu Wang, et al.
Free Radical Biology & Medicine|March 29, 2020
Urinary 8-oxo-7,8-dihydroguanosine as a potential biomarker of frailty for elderly patients with cardiovascular diseaseYao-Dan Liang, Qian Liu, Ming-Hui Du, et al.
Journal of Geriatric Cardiology : JGC|November 10, 2021
Lead dislodgement complicated with paroxysmal atrial fibrillation as a rare cause of inappropriate implantable cardioverter defibrillator shock: a case reportGao-Feng Lin, Tong Zou, Ming-Hui DU, et al.
Journal of the American Heart Association|April 30, 2024
Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic StatusXin Xu, Qing-Wen Ren, Chanchal Chandramouli, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Chemico-Biological Interactions|June 13, 2020
An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62Hao Chen, Da-Peng Dai, Shan Zhou, et al.
Frontiers in Pharmacology|December 30, 2022
Identification and drug metabolic characterization of four new CYP2C9 variants <i>CYP2C9*72</i>-<i>*75</i> in the Chinese Han populationFang-Ling Zhao, Qing Zhang, Shuang-Hu Wang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|February 15, 2014
[Glucometabolic abnormalities survey among outpatients without previous diabetes diagnosis and with coronary artery disease and hypertension]Yun-dai Chen, Dan-dan Li, Wei Dong, et al.
Clinical Interventions in Aging|January 8, 2020
Identification of Frailty and Its Risk Factors in Elderly Hospitalized Patients from Different Wards: A Cross-Sectional Study in ChinaYao-Dan Liang, Yao-Nan Zhang, Yan-Ming Li, et al.
Pharmacology Research & Perspectives|January 28, 2021
Functional characterization of the defective CYP2C9 variant CYP2C9*18Jian Liu, Hao Chen, Shuang-Hu Wang, et al.
Free Radical Biology & Medicine|March 29, 2020
Urinary 8-oxo-7,8-dihydroguanosine as a potential biomarker of frailty for elderly patients with cardiovascular diseaseYao-Dan Liang, Qian Liu, Ming-Hui Du, et al.
Journal of Geriatric Cardiology : JGC|November 10, 2021
Lead dislodgement complicated with paroxysmal atrial fibrillation as a rare cause of inappropriate implantable cardioverter defibrillator shock: a case reportGao-Feng Lin, Tong Zou, Ming-Hui DU, et al.
Journal of the American Heart Association|April 30, 2024
Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic StatusXin Xu, Qing-Wen Ren, Chanchal Chandramouli, et al.
Pageof 4